Filing Details

Accession Number:
0001209191-14-069212
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-17 16:30:41
Reporting Period:
2014-11-13
Filing Date:
2014-11-17
Accepted Time:
2014-11-17 16:30:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559231 Maria Fardis C/O Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale CA 94085
Chief Of Oncology Ops & Allian No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-13 3,000 $6.84 6,193 No 4 M Direct
Common Stock Disposition 2014-11-13 3,000 $141.30 3,193 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-11-13 3,000 $0.00 3,000 $6.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,500 2011-05-20 2021-05-20 No 4 M Direct
Footnotes
  1. The shares subject to the option will vest as follows: 16,250 of the total shares subject to the option (65,000 shares) vested on April 25, 2012 and 1/36th of the remaining shares will vest monthly thereafter.